Related Experiment Video
Updated: Sep 8, 2025
08:56
Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
Published on: November 30, 2022
2.9K
Drugging inflammation: Easier NSAID than done.
Nicoletta Caronni1, Renato Ostuni2
1San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.
Immunity
|June 15, 2022
Summary
Non-steroidal anti-inflammatory drugs (NSAIDs) activate the antioxidant transcription factor NRF2 in immune cells. This study reveals a new mechanism for how these common medications work.
Area of Science:
- Immunology
- Pharmacology
- Molecular Biology
Background:
- Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for pain and inflammation relief.
- The precise molecular mechanisms of NSAIDs, particularly their effects on immune cells, are not fully understood.
Purpose of the Study:
- To investigate a novel mechanism of action for commonly used NSAIDs.
- To explore the impact of NSAIDs on immune cell function and antioxidant pathways.
Main Methods:
- The study focused on the activation of the NRF2 pathway.
- Experiments were conducted using myeloid immune cells.
Main Results:
- NSAIDs were found to activate the antioxidant transcription factor NRF2.
- This activation occurs specifically within myeloid immune cells, revealing a new drug mechanism.
Conclusions:
- Common NSAIDs possess a previously unrecognized ability to modulate the immune system through NRF2 activation.
- This finding offers new insights into NSAID pharmacology and potential therapeutic strategies targeting immune responses.
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
176
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
176
01:29Drugs for Treatment of Ulcerative Colitis in IBD
235
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
235
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
229
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
229
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
594
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
594
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
199
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
199